Concentrix Corporation
CNXC
$28.95
-$0.60-2.03%
NASDAQ
| 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | |
|---|---|---|---|---|---|
| Revenue | 9.95B | 9.83B | 9.72B | 9.63B | 9.59B |
| Total Other Revenue | -- | 569.83M | 1.14B | 1.72B | 2.31B |
| Total Revenue | 9.95B | 9.83B | 9.72B | 9.63B | 9.59B |
| Cost of Revenue | 6.53B | 6.39B | 6.29B | 6.19B | 6.14B |
| Gross Profit | 3.43B | 3.44B | 3.43B | 3.44B | 3.45B |
| SG&A Expenses | 2.42B | 2.40B | 2.43B | 2.41B | 2.40B |
| Depreciation & Amortization | 432.17M | 434.33M | 436.65M | 441.43M | 448.24M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.38B | 9.22B | 9.16B | 9.04B | 8.99B |
| Operating Income | 572.10M | 605.27M | 558.72M | 583.16M | 599.29M |
| Income Before Tax | -1.25B | -1.18B | 376.86M | 291.84M | 327.24M |
| Income Tax Expenses | 73.31M | 96.70M | 60.75M | 47.20M | 57.87M |
| Earnings from Continuing Operations | -1.33K | -1.28K | 316.11 | 244.63 | 269.37 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.33B | -1.28B | 316.11M | 244.63M | 269.37M |
| EBIT | 572.10M | 605.27M | 558.72M | 583.16M | 599.29M |
| EBITDA | 1.23B | 1.27B | 1.22B | 1.25B | 1.28B |
| EPS Basic | -21.44 | -20.73 | 4.74 | 3.65 | 4.00 |
| Normalized Basic EPS | 2.90 | 3.40 | 3.15 | 2.58 | 2.89 |
| EPS Diluted | -21.44 | -20.73 | 4.74 | 3.65 | 4.00 |
| Normalized Diluted EPS | 2.90 | 3.39 | 3.15 | 2.58 | 2.89 |
| Average Basic Shares Outstanding | 249.30M | 252.06M | 254.31M | 256.37M | 258.28M |
| Average Diluted Shares Outstanding | 249.48M | 252.24M | 254.53M | 256.57M | 258.50M |
| Dividend Per Share | 1.39 | 1.36 | 1.33 | 1.30 | 1.27 |
| Payout Ratio | -6.81% | -7.01% | 28.16% | 35.72% | 31.77% |